Prodrugs
Research on prodrugs reported by scientists at University of California, Comprehensive Cancer Center
Published in Gene Therapy Weekly, September 20th, 2007
Scientists discuss in "AN-113, a novel prodrug of 4-phenylbutyrate with increased anti-neoplastic activity in glioma cell lines" new findings in prodrugs. According to recent research from the United States, "Butyroyloxymethyl-4-phenylbutyrate (AN-113) is a novel HDACI that releases potent anti-neoplastic derivatives upon intracellular hydrolysis. The precursor of AN-113, 4-phenylbutyrate has shown promising results in a Phase I study of gliomas, and we hypothesized that AN-113 offers significant advantages over the parent drug."
"AN-113 demonstrates selective in vitro cytotoxicity against malignant cells while sparing normal astrocytes, effective at doses over 20-fold...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2007-09-20)
More Articles from Gene Therapy Weekly
- Gene Therapy
Study details regulation of vital tumor suppressor gene p53 - Gene Therapy
CODA Genomics Announces Issuance of Optimized Synthetic Gene Production Patent - Gene Therapy
CytoGenix Announces Hiring of New Chief Financial Officer - Molecular Targets
The Molecular Profiling Institute Launches Mammostrat - a Novel, Molecular-Targeted, Prognostic Test for Breast Cancer Patients - Bioengineering
New bioengineering study findings reported from Martin-Luther University, Institute of Biochemistry and Biotechnology - Bioengineering
Research reports on bioengineering from Boston University, Center for Advanced Biotechnology provide new insights - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
